Federal and state governments' latest strategy in the fight to rein in the power of pharmacy benefit managers (PBMs) is ...
Among the delivery characteristics and neonatal outcomes, the researchers found a slightly lower rate of preterm birth (<37 ...
The authors concluded that the combination of supplements containing silicon dioxide, along with dietary and fluid restriction during Ramadan, likely increased the patient's risk for developing a ...
In " Beyond Diagnosis: CLL," Cleveland Clinic hematologist/oncologist Allison Winter, MD, and host John Mangels explore how clinicians can communicate effectively and empathetically with patients ...
Diet adherence also tended to be associated with lower risks of cause-specific mortalities, including cardiovascular, neurodegenerative, and respiratory diseases, as well as cancer, Liangkai Chen, PhD ...
Over nearly 8 years of follow-up, each 1-point increase in lifetime cognitive enrichment correlated with a 38% lower risk of Alzheimer's dementia (HR 0.62, 95% CI 0.52-0.73), reported Andrea Zammit, ...
The Trump administration on Thursday revoked a scientific finding that climate change is a danger to public health, an idea ...
The move to ease the restrictions was backed by The Menopause Society (TMS), which said the boxed warning "may have been a deterrent to the use of the low-dose vaginal estrogen, which is a safe and ...
Previous exposure to ibrutinib (Imbruvica) among patients with mantle cell lymphoma (MCL) was associated with improved efficacy after treatment with the chimeric antigen receptor (CAR) T-cell therapy ...
A first-of-its-kind clinical trial will compare the investigational chimeric antigen receptor (CAR) T-cell therapy rondecabtagene autoleucel (ronde-cel) against physician's choice of approved CAR ...
Among the more than half of practices surveyed that lost a physician to burnout in the last 3 years, three-quarters said "regulatory burden" played a role, said Jeffrey Smith, MBA, of the Medical ...
FDA vaccine chief Vinay Prasad, MD, MPH, who made the controversial decision to refuse to review Moderna's mRNA flu vaccine, has been accused of sexual harassment and berating staff. ( BioSpace) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results